Stichting Radboud universitair medisch centrum
Patent Applications and Registrations
Patent applications and USPTO patent grants for Stichting Radboud universitair medisch centrum.The latest application filed is for "antisense oligonucleotides rescue aberrant splicing of abca4".
- Stichting Radboud universitair medisch centrum - Nijmegen NL
| Patent | Date |
|---|---|
| Antisense oligonucleotides rescue aberrant splicing of ABCA4 App 20220290154 - Collin; Robert Wilhelmus Johanna ; et al. | 2022-09-15 |
| Antisense oligonucleotides for the treatment of usher syndrome type 2 Grant 11,414,662 - Van Wyk August 16, 2 | 2022-08-16 |
| Improved administration of glycylcyclines by inhalation App 20220233555 - van Ingen; Jakobus | 2022-07-28 |
| Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis App 20220235355 - Collin; Robert Wilhelmus Johanna ; et al. | 2022-07-28 |
| Heart Assist Device App 20220161017 - van Dort; Daniel Immanuel Michael | 2022-05-26 |
| Process for preparation of beads for imaging Grant 11,286,352 - Srinivas , et al. March 29, 2 | 2022-03-29 |
| Antisense oligonucleotides for the treatment of leber congenital amaurosis Grant 11,279,933 - Collin , et al. March 22, 2 | 2022-03-22 |
| Breath Sampler App 20220031189 - de Jonge; Marinus Isaak ; et al. | 2022-02-03 |
| Contrast agent and its use for imaging Grant 11,185,600 - Figdor , et al. November 30, 2 | 2021-11-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 